Efficacity, Safety and Cost of Intravenous Morphine Titration Alone or Combined to Ketamine
KEMO
1 other identifier
interventional
160
1 country
1
Brief Summary
This is a randomised, controlled, double blinded study comparing in the postoperative setting the analgesic efficacy, the safety and the cost in two groups of patients receiving in the postanesthesia care unit either intravenous morphine titration alone or intravenous morphine titration combined to ketamine.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable postoperative-pain
Started May 2003
Longer than P75 for not_applicable postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2009
CompletedFirst Submitted
Initial submission to the registry
June 16, 2010
CompletedFirst Posted
Study publicly available on registry
June 17, 2010
CompletedJune 17, 2010
June 1, 2010
5.7 years
June 16, 2010
June 16, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
analgesic efficacy
the analgesic efficacy, in two groups of patients recevieving in the postanesthesia care unit either intravenous morphine titration alone or intravenous morphine titration combined to ketamine
24 h
Study Arms (2)
treatment
EXPERIMENTALintravenous morphine titration combined to ketamine
placebo
PLACEBO COMPARATORmorphine titration alone
Interventions
intravenous morphine titration combined to ketamine
Eligibility Criteria
You may qualify if:
- Age \> 18 yrs
- scheduled surgery
- General anesthesia
- ASA I to III
- Able to use a VAS
- No psychological disorders, able to speak french
You may not qualify if:
- Age \< 18 yrs
- Locoregional anesthesia or analgesia
- Allergia to morphine or ketamine
- Morphine or ketamine contraindication
- Pregnancy or breast-feeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hopital Louis Mourier
Colombes, 92700, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hawa Keita
Assistance Publique - Hôpitaux de Paris
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 16, 2010
First Posted
June 17, 2010
Study Start
May 1, 2003
Primary Completion
January 1, 2009
Study Completion
January 1, 2009
Last Updated
June 17, 2010
Record last verified: 2010-06